Amylyx Pharmaceuticals, Inc. (AMLX)

33.98 -0.51 (-1.48%) USD  |  NASDAQ  |  Sep 03, 16:00
33.98 0.00 (0.00%) After-Hours: 20:00
More

Amylyx Pharmaceuticals Net Income (Annual) : -144.74M for Dec. 31, 2025

Net Income (Annual) Chart

View Net Income (Annual) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -144.74M
December 31, 2024 -301.74M
December 31, 2023 49.27M
December 31, 2022 -198.38M
Date Value
December 31, 2021 -87.93M
December 31, 2020 -42.28M
December 31, 2019 -13.72M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Pfizer Inc. 7.787B
Eli Lilly & Co. 20.64B
Merck & Co., Inc. 18.26B
EyePoint, Inc. -231.96M
Bristol Myers Squibb Co. 7.056B